Paraplatin NovaPlus and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Paraplatin NovaPlus and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Paraplatin NovaPlus-Tafenoquine Succinate (Arakoda)
- Paraplatin NovaPlus-Tafenoquine Succinate (Krintafel)
- Paraplatin NovaPlus-Tafinlar
- Paraplatin NovaPlus-Tafluprost
- Paraplatin NovaPlus-Tafluprost ophthalmic
- Paraplatin NovaPlus-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Parathyroid hormone
- Tafenoquine (Prevention of Malaria Relapse)-Parathyroid hormone Subcutaneous
- Tafenoquine (Prevention of Malaria Relapse)-Parcopa
- Tafenoquine (Prevention of Malaria Relapse)-Paregoric
- Tafenoquine (Prevention of Malaria Relapse)-Paremyd
- Tafenoquine (Prevention of Malaria Relapse)-Paremyd Ophthalmic